



- Stock: In Stock
- Model: 183751
0% Customers recommend this product
-
5 Awesome0%
-
4 Great0%
-
3 Average0%
-
2 Bad0%
-
1 Poor0%
Reviews Over Oltar of the tab. of 4 mg No. 30
- (0)
Total Reviews (0)
click here write review to add review for this product.
Report this review.
Description
tablets Oltar are shown for treatment of diabetes of the II type at adults when only a diet, physical activity and decrease in body weight are insufficient for maintenance of level of glucose in blood.
Structure
Active ingredient: glimepirid;
1 tablet supports a glimepirid of 4 mg or 6 mg;
Excipients: lactose, starch corn, starch sodium (type A), povidone, polysorbate 80, ferrous oxide yellow (E172), talc, magnesium stearate.
Contraindication
Hypersensitivity to a glimepirid, to any of excipients or other derivatives of sulphonylurea or streptocides. Diabetes. Diabetic coma. Diabetic ketoacidosis. Heavy renal failures or liver. In case of heavy renal failures or a liver it is necessary conversion to insulin.
Route of administration Medicine is intended toby
for oral administration.
Guarantee of successful treatment of diabetes is the correct diet, regular physical activity and also periodic check of level of glucose in blood and urine. Oral antidiabetic medicaments or insulin cannot compensate non-compliance by the patient with the recommended diet.
Dosage is defined by the doctor by results of sugar level researches in blood and urine.
toFeature of use
toPregnant
toIt is contraindicated.
byChildren
it is not applied.
Drivers
With care.
OverdoseOverdose can lead
to a hypoglycemia which lasts from 12 to 72 hours and after the first simplification can repeatedly appear. Symptoms can be shown in 24 hours, after medicament absorption. As a rule, for such patients the observation in clinic is recommended. There can be nausea, vomiting and pain in anticardium. The hypoglycemia can often be followed by neurologic symptoms, such as concern, tremor, visual disturbances, lack of coordination, drowsiness, coma and spasms. Side effects
from blood and lymphatic system: thrombocytopenia, a leukopenia, a granulocytopenia, an agranulocytosis, an erythropenia, hemolytic anemia and a pancytopenia which, as a rule, are reversible after medicament withdrawal.
from digestive tract: nausea, vomiting, diarrhea, feeling of heavy and discomfort in a stomach, an abdominal pain, seldom result in need of the termination of treatment.
Interaction
Antagonists of N 2 receptors, can lead beta-blockers, a clonidine and reserpine both to potentiation, and to easing of effect of decrease in level of glucose in blood. Under the influence of sympatholytics, such as beta-blockers, clonidine, guanetidin and reserpine, manifestations of adrenergic reverse regulation of a hypoglycemia can decrease or disappear. Alcohol intake can strengthen or weaken hypoglycemic action of a glimepirid in an unpredictable way.
Storage conditionsto Store
at a temperature not above 30 °C. to Store
in original packing.
to Storeout of children's reach.
Expiration date - 2 years.
Specifications
Characteristics | |
Active ingredients | Glimepirid |
Amount of active ingredient | 4 mg |
Applicant | Berlin-Chemie Menarini |
Code of automatic telephone exchange | A10BB12 Glimepirid |
Interaction with food | In time |
Light sensitivity | Not sensitive |
Market status | The branded generic |
Origin | Chemical |
Prescription status | According to the prescription |
Primary packing | blister |
Producer | MENARINI MANUFACTURING LOGISTICS OF END S.R. SERVISES. L. |
Quantity in packing | 30 tablets |
Release form | tablets for internal use |
Route of administration | Oral |
Sign | Import |
Storage temperature | from 5 °C to 30 °C |
Trade name | Oltar |